Determination of glycosaminoglycan (GAG) content: The synthesised GAG was determined by binding to DMB dye and the total amount of GAG was normalised to the amount of DNA by a PicoGreen dsDNA assay. mRNA expression assay: Expressions of type I, II, X collagen, SOX-9, and aggrecan were analysed by real-time PCR. Expression of GAPDH was taken as an internal control. Histologic and immunohistochemical examination: Pellets from each time point were stained with H&E and safranin-O for proteoglycan detection. The expression of type II collagen was detected by immunohistochemical (IHC) staining. Results: Co-culture of human SDSCs and chondrocytes exhibited significantly higher GAG synthesis and type II collagen content. Furthermore, expression of type X collagen, a marker of MSC hypertrophy, was significantly lower in the coculture pellets. The co-culture groups exhibited up-regulation of type II collagen and Sox-9 at seven days, and type I collagen, type X collagen, and aggrecan at 14 days. Safranin-O staining and IHC staining for type II collagen showed that chondrogenic differentiation of the co-culture group were higher than those of the chondrocytes or SDSCs single culture groups. Introduction: Platelet-rich plasma (PRP) has been advocated as one treatment strategy for cartilage tissue regeneration. To date, several different plateletrich formulations have been made available, but a deep knowledge of their composition and mechanism of action in a specific clinical use is needed. There are many variations in PRP formulations, with both platelet and leukocyte concentrations having been identified as major constituents affecting the inflammatory responses after PRP injection. The aim of this study was to investigate the effect of leukocyte depletion in PRP on the proliferation and chondrogenesis of synovium-derived MSCs (SD-MSCs) and chondrocytes. Methods: Preparation of PRP formulations: From donated human fresh blood, we prepared three formulations of PRP: (1) platelet-poor plasma (PPP), (2) PRP with very few leukocytes (P-PRP), and (3) PRP with high concentrations of both platelets and leukocytes (L-PRP). PPP is the upper layer of plasma after centrifuging 10cc whole blood at 2400rpm for 10 minutes. After 2nd centrifuging at 3600rpm for 15 minutes, P-PRP is the lower layer of plasma without buffy coat. L-PRP is the lower layer of plasma with buffy coat. Cell culture and in-vitro expansion: SD-MSCs and chondrocytes were obtained from patients undergoing total knee arthroplasty. The primary cells were expanded in DMEM with the three formulations. The cell proliferation was measured using the MTT assay. Chondrogenesis: Chondrogenic differentiation of SD-MSCs and expanded chondrocytes were induced using a high-density pellet culture system. Aliquots of 5Â10 5 cells were centrifuged at 500g for 5 minutes, which were subsequently cultured for three weeks. The pellets of SD-MSCs and chondrocytes were cultured in chemically defined chondrogenic medium with 10 ng/ml of TGF-b1 and/or 100 ng/ml of BMP-2. Real-time PCR: Total RNA from SD-MSCs and chondrocytes were extracted by using the RNeasy mini kit (Qiagen). Expressions of type II collagen, type X collagen, Aggrecan, and Sox9 were analysed by RT-PCR. Expression of GAPDH was taken as the internal control. Histological and immunohistochemical examination: Pellets were stained with Safranin-O for proteoglycan detection. The expression of type II collagen was detected by IHC staining and was observed under microscopy. Results: Leukocyte depletion also lowered the count of platelets. L-PRP showed more proliferative effect on SD-MSCs and chondrocytes than P-PRP. RT-PCR revealed higher cartilage gene expression in TGF-b1 induced chondrogenesis of SD-MSCs and chondrocytes with P-PRP. However, there was a negative effect of both formulations in TGF-b1/BMP induced chondrogenesis. In TGF-b1 and/or BMP induced chondrogenesis, the SD-MSC pellet with P-PRP showed more proteoglycan production than those with L-PRP. Type II collagen synthesis in the chondrocyte pellets with P-PRP was greater than the pellets with L-PRP. However, type II collagen synthesis in SD-MSCs pellets was not detected. Discussion: Although leukocyte depletion in PRP showed a negative effect on proliferation of SD-MSCs and chondrocytes and a positive effect on the mRNA expression of the chondrogenic differentiation marker genes, it could not change the negative effects of PRP on chondrogenic differentiation of SDMSCs. http://dx.doi.org/10.1016/j.jot.2016.06.121
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